KBC and SR One lead €40m Ablynx financing

KBC Private Equity, a Belgian private equity firm, has made its second investment in a Belgian biotechnology firm this week by leading a €40m Series financing for Ablynx, which develops protein products for serious diseases including Alzheimer’s.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this